NIA Small Business Programs: An Overview
NIA's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support small business concerns and nonprofit research organizations that conduct research leading to the development of products and services that improve the health and well-being of older Americans. All NIA research divisions participate in SBIR/STTR programs.
The goal of NIA small business programs is to translate research on aging, aging-related conditions and diseases, and the special problems and needs of older Americans into innovative programs, systems, networks, and products or services. These innovations will be used by health-care professionals, informal caregivers, and older adults to advance the health and well-being of older Americans and their families.
All applicants are expected to develop, implement, and test the efficacy of their products and services. The SBIR-STTR programs target early-stage research and development and encompass a broad range of research topics and types of research and product development, including translational and secondary research and product development.
Special Focus on Alzheimer's Disease and Related Dementias
The National Institute on Aging expects to provide over $80 million in funding for small business innovation in aging and Alzheimer’s disease in fiscal year 2018. The NIA Small Business program offers no-strings-attached, non-dilutive funding up to $1.5 million to commercialize products that address aging and aging-related diseases and conditions.
NIA is the lead federal agency addressing research on Alzheimer’s disease (AD) and AD-related dementias (ADRD) and has been granted an unprecedented research and development (R&D) budget to address and develop interventions and therapeutics that prevent the onset of AD and ADRD, or may lead to a cure.
Consequently, NIA urgently seeks applications to its Small Business Programs (SBIR & STTR) that focus on commercialization—including drug development, of AD- and ADRD-focused R&D.
To meet its goals, NIA realizes it must attract small businesses with new and different ideas and approaches. Furthermore, NIA must reach out to and attract small businesses that have never before considered or participated in NIA’s Small Business Programs.
To this end, NIA strongly encourages small businesses that may have not previously considered or participated in AD- or ADRD-targeted therapeutic drug development to contact NIA about its Small Business R & D Programs. More than that, NIA invites such companies to develop and submit applications to NIA’s Small Business (SBIR-STTR) Programs.